UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 86

Sortiert nach

Prise en charge de l’anémie en oncologie: modalités pratiques, efficacité des agents stimulant l’érythropoïèse (ASE) [darbépoétine alpha] et place de la transfusion

Oncologie (Paris, France), 2012-02, Vol.14 (2), p.123-130

2012

Link zum Volltext

Verfügbarkeit prüfen

Predictive factors of depressive symptoms of elderly patients with cancer receiving first‐line chemotherapy

Psycho-oncology (Chichester, England), 2017-01, Vol.26 (1), p.15-21

2017

Link zum Volltext

Verfügbarkeit prüfen

Enzalutamide and sleep apnea: an emerging central nervous system side-effect?

Annals of oncology, 2016-01, Vol.27 (1), p.206-206

2016

Link zum Volltext

Verfügbarkeit prüfen

Phase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients (pts) over 70 with previously treated metastatic colorectal adenocarcinoma (mCRC) FFCD 1404 - REGOLD

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii156

2018

Link zum Volltext

Verfügbarkeit prüfen

Hépatocholangiocarcinome à différenciation neuroendocrine : une entité exceptionnelle, paradigme du concept de cellule souche hépatique

Annales de pathologie, 2015-10, Vol.35 (5), p.469-469

2015

Link zum Volltext

Verfügbarkeit prüfen

PP111-SUN THE EFFECTS OF NUTRITIONAL ADVICES IN OLDER PATIENTS AT RISK FOR MALNUTRITION DURING CHEMOTHERAPY FOR CANCER ON THE QUALITY OF INTAKES. MULTICENTRE INOGAD STUDY

Clinical nutrition (Edinburgh, Scotland), 2013-09, Vol.32, p.S64-S64

2013

Link zum Volltext

Verfügbarkeit prüfen

A randomized phase II trial evaluating safety and efficacy of an experimental chemotherapy regimen (irinotecan + oxaliplatin, IRINOX) and two standard arms (LV5–FU2 + irinotecan or LV5–FU2 + oxaliplatin) in first-line metastatic colorectal cancer: a study of the Digestive Group of the Fédération Nationale des Centres de Lutte Contre le Cancer

Annals of oncology, 2007-12, Vol.18 (12), p.2000-2005

2007

Link zum Volltext

Verfügbarkeit prüfen

Capecitabine plus oxaliplatin (XELOX) versus 5‐fluorouracil/leucovorin plus oxaliplatin (FOLFOX‐6) as first‐line treatment for metastatic colorectal cancer

International journal of cancer, 2011-02, Vol.128 (3), p.682-690

2011

Link zum Volltext

Verfügbarkeit prüfen

Nutritional Advices in Older Patients at Risk for Malnutrition During Chemotherapy for Cancer: No Effect on Mortality Decreased Rate or Severe Infections. Multicentre Inogad Study

Journal of geriatric oncology, 2013-10, Vol.4, p.S19-S19

2013

Link zum Volltext

Verfügbarkeit prüfen

Standards, Options et Recommandations 2001 pour la radiothérapie des patientes atteintes d'un cancer du sein infiltrant non métastatique, mise à jour

Cancer radiothérapie, 2002-06, Vol.6 (4), p.238-258

2002

Link zum Volltext

Verfügbarkeit prüfen

394P Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon adenocarcinoma from PRODIGE 34-FFCD 1402-ADAGE randomized phase III trial

Annals of oncology, 2021-09, Vol.32, p.S535-S535

2021

Link zum Volltext

Verfügbarkeit prüfen

398O Effect of 5 years of imaging and CEA follow-up to detect recurrence of colorectal cancer (CRC) - PRODIGE 13 a FFCD phase III trial

Annals of oncology, 2020-09, Vol.31, p.S410-S410

2020

Link zum Volltext

Verfügbarkeit prüfen

Tumor lysis syndrome at the beginning of thalidomide therapy for multiple myeloma

Journal of clinical oncology, 2002-04, Vol.20 (8), p.2212

2002

Link zum Volltext

Verfügbarkeit prüfen

Prise en charge de l’anémie en oncologie : modalités pratiques, efficacité des agents stimulant l’érythropoïèse ASE (Darbepoetin alfa) et place de la transfusion

Revue d'épidémiologie et de santé publique, 2009-10, Vol.57, p.S71-S71

2009

Link zum Volltext

Verfügbarkeit prüfen

Subcutaneous interleukin-2, interferon alpha-2b and 5-fluorouracil in metastatic renal cell carcinoma as second-line treatment after failure of previous immunotherapy: a phase II trial

British journal of cancer, 2003-12, Vol.89 (12), p.2213-2218

2003

Link zum Volltext

Verfügbarkeit prüfen

Predictive factors of depressive symptoms of elderly patients with cancer receiving first-line chemotherapy: Depression of elderly patients with cancer during chemotherapy

Psycho-oncology (Chichester, England), 2017-01, Vol.26 (1), p.15-21

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract GS2-07: PHARE randomized trial final results comparing 6 to 12 months of trastuzumab in adjuvant early breast cancer

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.GS2-07-GS2-07

2019

Link zum Volltext

Verfügbarkeit prüfen

OP037 NUTRITIONAL ADVICES IN OLDER PATIENTS AT RISK FOR MALNUTRITION DURING CHEMOTHERAPY FOR CANCER: NO EFFECT ON MORTALITY DECREASED RATE OF SEVERE INFECTIONS. MULTICENTRE INOGAD STUDY

Clinical nutrition. Supplements, 2012-09, Vol.7 (1), p.16-16

2012

Link zum Volltext

Verfügbarkeit prüfen

3053 Management of anaemia in oncology: use and efficacy of Darbepoetin alfa in CIA patients

European journal of cancer supplements, 2009, Vol.7 (2), p.191-191

2009

Link zum Volltext

Verfügbarkeit prüfen

Summary version of the standards, options and recommendations for nonmetastatic breast cancer (updated January 2001)

British journal of cancer, 2003-08, Vol.89 (S1), p.S17-S31

2003

Link zum Volltext

Verfügbarkeit prüfen

Granulocyte-macrophage colony-stimulating factor in patients with neutropenic fever is potent after low-risk but not after high-risk neutropenic chemotherapy regimens: results of a randomized phase III trial

Journal of clinical oncology, 1998-09, Vol.16 (9), p.2930-2936

1998

Link zum Volltext

Verfügbarkeit prüfen

Effect of 5 years of imaging and CEA follow-up to detect recurrence of colorectal cancer - PRODIGE 13 a FFCD and Unicancer phase III trial: baseline characteristics

Annals of oncology, 2016-10, Vol.27, p.vi159-vi159

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 86

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(67)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(40)
Science & Technology
(30)
Life Sciences & Biomedicine
(27)
Oncology
(24)
Female
(22)
Aged
(20)
Adult
(16)
Male
(15)
Middle Aged
(15)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(11)
Biological And Medical Sciences
(11)
Medical Sciences
(11)
Aged, 80 And Over
(8)
Cancer
(8)
Life Sciences
(8)
Chemotherapy
(7)
Child
(7)
France
(7)
Neoplasm Staging
(7)
Adolescent
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prise en charge de l’anémie en oncologie: modalités pratiques, efficacité des agents stimulant l’érythropoïèse (ASE) [darbépoétine alpha] et place de la transfusion

Predictive factors of depressive symptoms of elderly patients with cancer receiving first‐line chemotherapy

Enzalutamide and sleep apnea: an emerging central nervous system side-effect?

Phase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients (pts) over 70 with previously treated metastatic colorectal adenocarcinoma (mCRC) FFCD 1404 - REGOLD

Hépatocholangiocarcinome à différenciation neuroendocrine : une entité exceptionnelle, paradigme du concept de cellule souche hépatique

PP111-SUN THE EFFECTS OF NUTRITIONAL ADVICES IN OLDER PATIENTS AT RISK FOR MALNUTRITION DURING CHEMOTHERAPY FOR CANCER ON THE QUALITY OF INTAKES. MULTICENTRE INOGAD STUDY

Nutritional advice in older patients at risk of malnutrition during treatment for chemotherapy: a two-year randomized controlled trial

Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon cancer from the PRODIGE 34-FFCD randomized trial

Capecitabine plus oxaliplatin (XELOX) versus 5‐fluorouracil/leucovorin plus oxaliplatin (FOLFOX‐6) as first‐line treatment for metastatic colorectal cancer

Nutritional Advices in Older Patients at Risk for Malnutrition During Chemotherapy for Cancer: No Effect on Mortality Decreased Rate or Severe Infections. Multicentre Inogad Study

Standards, Options et Recommandations 2001 pour la radiothérapie des patientes atteintes d'un cancer du sein infiltrant non métastatique, mise à jour

394P Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon adenocarcinoma from PRODIGE 34-FFCD 1402-ADAGE randomized phase III trial

398O Effect of 5 years of imaging and CEA follow-up to detect recurrence of colorectal cancer (CRC) - PRODIGE 13 a FFCD phase III trial

Tumor lysis syndrome at the beginning of thalidomide therapy for multiple myeloma

Prise en charge de l’anémie en oncologie : modalités pratiques, efficacité des agents stimulant l’érythropoïèse ASE (Darbepoetin alfa) et place de la transfusion

Subcutaneous interleukin-2, interferon alpha-2b and 5-fluorouracil in metastatic renal cell carcinoma as second-line treatment after failure of previous immunotherapy: a phase II trial

Predictive factors of depressive symptoms of elderly patients with cancer receiving first-line chemotherapy: Depression of elderly patients with cancer during chemotherapy

Abstract GS2-07: PHARE randomized trial final results comparing 6 to 12 months of trastuzumab in adjuvant early breast cancer

Single-arm phase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients over 70 with previously treated metastatic colorectal adenocarcinoma FFCD 1404 – REGOLD

OP037 NUTRITIONAL ADVICES IN OLDER PATIENTS AT RISK FOR MALNUTRITION DURING CHEMOTHERAPY FOR CANCER: NO EFFECT ON MORTALITY DECREASED RATE OF SEVERE INFECTIONS. MULTICENTRE INOGAD STUDY

3053 Management of anaemia in oncology: use and efficacy of Darbepoetin alfa in CIA patients

Summary version of the standards, options and recommendations for nonmetastatic breast cancer (updated January 2001)

Granulocyte-macrophage colony-stimulating factor in patients with neutropenic fever is potent after low-risk but not after high-risk neutropenic chemotherapy regimens: results of a randomized phase III trial

Effect of 5 years of imaging and CEA follow-up to detect recurrence of colorectal cancer - PRODIGE 13 a FFCD and Unicancer phase III trial: baseline characteristics

Suchergebnisse filtern